Portland biotech company has big plans for its cardiovascular drugs
Aronora has secured $25 million in grants but is seeking a partner to take its drug candidates into Phase 3 clinical trials.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Elizabeth Hayes Source Type: news
More News: American Health | Biotechnology | Cardiology | Cardiovascular | Clinical Trials | Grants | Health Management | Heart